Churchill Resources (CRI) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free CRI Stock Alerts C$0.06 +0.01 (+10.00%) (As of 05:33 PM ET) Add Compare Share Share ChartStock AnalysisChartInsider TradesStock AnalysisChartInsider Trades Churchill Resources Stock Price Performance5 Day Performance+10.00%1 Month Performance-8.33%3 Month Performance-15.38%6 Month Performance+22.22%Year-To-Date Performance-35.29%1 Year Performance-52.17% Receive CRI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Churchill Resources and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. CRI Stock Chart for Wednesday, May, 8, 2024 CRI Chart by TradingView Churchill Resources Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024C$0.05C$0.06+10.00%C$0.06C$0.06100,000 shsC$7.81 million05/07/2024C$0.05C$0.05C$0.05C$0.05136,500 shsC$7.10 million05/06/2024C$0.05C$0.05C$0.05C$0.0550,000 shsC$7.10 million05/03/2024C$0.05C$0.05C$0.05C$0.0550,000 shsC$7.10 million05/02/2024C$0.05C$0.05C$0.05C$0.0550,000 shsC$7.10 million05/01/2024C$0.05C$0.05C$0.05C$0.0550,000 shsC$7.10 million Get the Latest News and Ratings for CRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Churchill Resources and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024C$0.05C$0.05C$0.05C$0.0550,000 shsC$7.10 million04/29/2024C$0.05C$0.05+11.11%C$0.05C$0.0550,000 shsC$7.10 million04/26/2024C$0.05C$0.05C$0.05C$0.05110,000 shsC$6.39 million04/25/2024C$0.05C$0.05C$0.05C$0.05110,000 shsC$6.39 million04/24/2024C$0.05C$0.05-10.00%C$0.05C$0.04301,000 shsC$6.39 million04/23/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/22/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/19/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/18/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/17/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/16/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/15/2024C$0.05C$0.05C$0.05C$0.05143,000 shsC$7.10 million04/12/2024C$0.06C$0.05-16.67%C$0.05C$0.05143,000 shsC$7.10 million04/11/2024C$0.06C$0.06C$0.06C$0.06125,000 shsC$8.52 million04/10/2024C$0.06C$0.06C$0.06C$0.06125,000 shsC$8.52 million04/09/2024C$0.06C$0.06C$0.06C$0.06125,000 shsC$8.52 million04/08/2024C$0.06C$0.06C$0.06C$0.06125,000 shsC$8.52 million04/05/2024C$0.06C$0.06+9.09%C$0.06C$0.06125,000 shsC$8.52 million04/04/2024C$0.05C$0.06+10.00%C$0.06C$0.0571,000 shsC$7.81 million04/03/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million04/02/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million04/01/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million03/29/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million03/28/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million03/27/2024C$0.05C$0.05C$0.05C$0.0517,000 shsC$7.10 million03/26/2024C$0.05C$0.05C$0.05C$0.053,018 shsC$7.10 million03/25/2024C$0.05C$0.05+11.11%C$0.05C$0.053,018 shsC$7.10 million03/22/2024C$0.05C$0.05C$0.05C$0.05231,200 shsC$6.39 million03/21/2024C$0.05C$0.05C$0.05C$0.05231,200 shsC$6.39 million03/20/2024C$0.05C$0.05-10.00%C$0.05C$0.05231,200 shsC$6.39 million03/19/2024C$0.04C$0.05+25.00%C$0.05C$0.0510,000 shsC$7.10 million03/18/2024C$0.04C$0.04C$0.04C$0.049,000 shsC$5.68 million03/15/2024C$0.04C$0.04C$0.04C$0.049,000 shsC$5.68 million03/14/2024C$0.04C$0.04C$0.04C$0.049,000 shsC$5.68 millionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/13/2024C$0.05C$0.04-20.00%C$0.04C$0.049,000 shsC$5.68 million03/12/2024C$0.05C$0.05+11.11%C$0.05C$0.0520,000 shsC$7.10 million03/11/2024C$0.05C$0.05-10.00%C$0.05C$0.0521,030 shsC$6.39 million03/08/2024C$0.05C$0.05C$0.05C$0.0549,000 shsC$7.10 million03/07/2024C$0.05C$0.05C$0.05C$0.0549,000 shsC$7.10 million03/06/2024C$0.05C$0.05C$0.05C$0.0549,000 shsC$7.10 million03/05/2024C$0.05C$0.05C$0.05C$0.0549,000 shsC$7.10 million03/04/2024C$0.05C$0.05+11.11%C$0.05C$0.0516,000 shsC$7.10 million03/01/2024C$0.05C$0.05C$0.05C$0.051,500 shsC$6.39 million02/29/2024C$0.05C$0.05-10.00%C$0.05C$0.051,500 shsC$6.39 million02/28/2024C$0.05C$0.05C$0.05C$0.0510,000 shsC$7.10 million02/27/2024C$0.05C$0.05C$0.05C$0.05451,000 shsC$7.10 million02/26/2024C$0.06C$0.05-9.09%C$0.06C$0.0586,000 shsC$7.10 million02/23/2024C$0.06C$0.06C$0.06C$0.0610,000 shsC$7.81 million02/22/2024C$0.06C$0.06C$0.06C$0.0610,000 shsC$7.81 million02/21/2024C$0.06C$0.06C$0.06C$0.0610,000 shsC$7.81 million02/20/2024C$0.06C$0.06C$0.06C$0.06100,000 shsC$7.81 million02/19/2024C$0.06C$0.06C$0.06C$0.06100,000 shsC$7.81 million02/16/2024C$0.06C$0.06-8.33%C$0.06C$0.06100,000 shsC$7.81 million02/15/2024C$0.06C$0.06C$0.06C$0.0640,000 shsC$8.52 million02/14/2024C$0.06C$0.06C$0.06C$0.0640,000 shsC$8.52 million02/13/2024C$0.06C$0.06C$0.06C$0.0640,000 shsC$8.52 million02/12/2024C$0.06C$0.06C$0.06C$0.0640,000 shsC$8.52 million02/09/2024C$0.07C$0.06-7.69%C$0.06C$0.0640,000 shsC$8.52 million02/08/2024C$0.07C$0.07C$0.07C$0.0750,000 shsC$9.23 million02/07/2024C$0.07C$0.07C$0.07C$0.0725,000 shsC$9.23 million Related Companies: Goldstar Minerals Stock Price Chart First Atlantic Nickel Stock Price Chart Whitemud Resources Stock Price Chart Portofino Resources Stock Price Chart Silver Bull Resources Stock Price Chart Wolfden Resources Stock Price Chart International Lithium Stock Price Chart Oceanic Iron Ore Stock Price Chart Chatham Rock Phosphate Stock Price Chart Sparton Resources Stock Price Chart Receive CRI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Churchill Resources and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:CRI) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Churchill Resources Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
